As Bill Weldon leaves the headquarters of Johnson & Johnson (NYSE: JNJ), probably many years from now, he will know that his tenure will be remembered for hip replacement and children’s Tylenol recalls and not good earnings reports.
Weldon, only 63, was replaced as CEO today, but will stay chairman. Weldon’s replacement, Alex Gorsky, is only 51. He has been Vice Chairman of the Company’s Executive Committee with responsibility for the Medical Devices & Diagnostics Group, Global Supply Chain, Health Care Compliance & Privacy and Government Affairs & Policy. In the normal course of things, he probably could have waited a few years for the promotion.
But, it is not the normal course. J&J once had a sterling brand image. It will be tarnished for years by the recalls.
Over the last five years, the J&J share price is flat
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
